Fiduciary Planning LLC Abb Vie Inc. Transaction History

Fiduciary Planning LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$131.98 - $163.75 $500,996 - $621,595	-3,796 Closed	0 $0
Q4 2021 Feb 08, 2022	SELL	$107.43 - $135.93 $769,950 - $974,210	-7,167 Reduced 65.37%	3,796 $514,000
Q3 2021 Nov 09, 2021	SELL	$106.4 - $120.78 $139,916 - $158,825	-1,315 Reduced 10.71%	10,963 $1.18 Million
Q2 2021 Aug 06, 2021	SELL	$105.21 - $117.21 $616,425 - $686,733	-5,859 Reduced 32.3%	12,278 $1.38 Million
Q1 2021 May 24, 2021	BUY	$102.3 - $112.62 $54,423 - $59,913	532 Added 3.02%	18,137 $1.96 Million
Q4 2020 Feb 10, 2021	BUY	$80.49 - $108.67 $1.42 Million - $1.91 Million	17,605 New	17,605 $1.89 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $317B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Fiduciary Planning LLC, based on Form 13F filings with the SEC.

Stay updated on Fiduciary Planning LLC with notifications on news.